Spinal Levobupivacaine for Caesarean Delivery: A dose response comparison with Spinal Bupivacaine

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002923

Enrollment

Unknown

Registered

2012-12-29

Start date

2002-05-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Pregnant patients presenting for Elective Caesarean Delivery

Interventions

Two groups:Levobupivacaine vs Bupivacaine

Eligibility

Sex/Gender

Male

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Healthy ASA 1 & 2 patients presenting for elective Caesarean Delivery under spinal anaesthesia

Exclusion criteria

Exclusion criteria: Patients who do not conform to the inclusion criteria, including those with neurological disease, coagulopathy, heart disease

Design outcomes

Primary

Measure	Time frame
successful response;	—

Countries

China

Contacts

Public ContactKhaw Kim Sun

kimkhaw@cuhk.edu.hk+852 26322735

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026